DBV Technologies S.A. (EPA:DBV)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Conducting of Research and Development of Epicutaneous Immunotherapy Products	4.15M	15.73M	4.84M	5.71M	11.28M
Conducting of Research and Development of Epicutaneous Immunotherapy Products Growth	-73.61%	224.69%	-15.14%	-49.38%	-23.33%
Total	4.15M	15.73M	4.84M	5.71M	11.28M
Total Growth	-73.61%	224.69%	-15.14%	-49.38%	-23.33%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
France	4.15M	15.73M	4.84M	5.71M	11.28M
France Growth	-73.61%	224.69%	-15.14%	-49.38%	-23.33%
Total	4.15M	15.73M	4.84M	5.71M	11.28M
Total Growth	-73.61%	224.69%	-15.14%	-49.38%	-23.33%

Source: S&P Global Market Intelligence.